UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...

UnitedHealth Q4 earnings beat EPS estimates at $6.81 but missed revenue projections. Analysts highlight growth potential in ...

KeyBanc Capital Markets reiterated its Overweight rating on UnitedHealth Group shares (NYSE:UNH), maintaining a price target ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

The Biden administration said a record 24.2 million Americans enrolled in individual coverage under the Affordable Care Act ...

Healthcare fraud investigations accounted for more than half of the Department of Justice's settlements and judgments in 2024 ...

FDA Commissioner Robert Califf is closing the book on his second stint leading the agency that regulates products accounting ...

As government scrutiny and enforcement targeting the Medicare Advantage (Medicare Part C) program continued in 2024, the ...

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on UnitedHealth (UNH – Research Report). The associated price target ...

Witty's comments came during the company's first earnings call since the killing of Brian Thompson, the CEO of the company's insurance arm UnitedHealthcare.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden adds Ozempic to list for Medicare price negotiationIn one of its last actions, the Biden ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...